Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.
Glenn Coleman, insider at Integra LifeSciences

Glenn Coleman Insider Information

GLENN G. COLEMAN is Integra’s Executive Vice President and Chief Operating Officer. Mr. Coleman oversees Integra operations and approximately 60% of Integra’s talent force, including clinical, R&D, manufacturing, quality, and business development while also leading our international team. Prior to his promotion in June 2019 to Chief Operating Officer, he acted as the Company’s Chief Financial Officer and was responsible for the finance department, including accounting and financial reporting, budgeting, internal audit, tax, treasury, investor relations, and information technology while also leading our international business. Prior to joining the Company in May 2014 as Corporate Vice President and Chief Financial Officer, he spent 25 years in financial management positions with leading global businesses, including serving as vice president for finance and corporate controller at Curtiss-Wright Corporation. He also worked at Alcatel-Lucent in various finance executive leadership positions. Mr. Coleman began his career at PricewaterhouseCoopers LLP as lead senior manager for a top global account. Mr. Coleman received his B.S. degree from Montclair State University and has also been a CPA in New Jersey for more than 25 Provided by Tagnifi.

What is Glenn Coleman's net worth?

The estimated net worth of Glenn Coleman is at least $2.47 million as of April 4th, 2022. Mr. Coleman owns 41,288 shares of Integra LifeSciences stock worth more than $2,473,151 as of May 22nd. This net worth approximation does not reflect any other assets that Mr. Coleman may own. Additionally, Mr. Coleman receives a salary of $927,950.00 as COO at Integra LifeSciences. Learn More about Glenn Coleman's net worth.

How old is Glenn Coleman?

Mr. Coleman is currently 54 years old. There are 8 older executives and no younger executives at Integra LifeSciences. Learn More on Glenn Coleman's age.

What is Glenn Coleman's salary?

As the COO of Integra LifeSciences Holdings Co., Mr. Coleman earned a total compensation package of $2,827,990.00 in 2020. Mr. Coleman earned a salary of $559,615.00, stock awards of $1,330,034.00, options awards of $570,010.00, non-equity compensation of $360,000.00, and other compensation of $8,331.00. Learn More on Glenn Coleman's salary.

How do I contact Glenn Coleman?

The corporate mailing address for Mr. Coleman and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected] Learn More on Glenn Coleman's contact information.

Has Glenn Coleman been buying or selling shares of Integra LifeSciences?

Over the course of the past ninety days, Glenn Coleman has sold $413,938.72 in Integra LifeSciences stock. As an example of a recent trade by , on Sunday, May 22nd, 0 shares of BMO Capital Markets stock. Learn More on Glenn Coleman's trading history.

Who are Integra LifeSciences' active insiders?

Integra LifeSciences' insider roster includes Glenn Coleman (COO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), and Jeffrey Mosebrook (SVP). Learn More on Integra LifeSciences' active insiders.

Are insiders buying or selling shares of Integra LifeSciences?

In the last year, insiders at the life sciences company sold shares 8 times. They sold a total of 515,246 shares worth more than $34,804,750.88. The most recent insider tranaction occured on April, 4th when COO Glenn Coleman sold 6,268 shares worth more than $413,938.72. Insiders at Integra LifeSciences own 4.2 % of the company. Learn More about insider trades at Integra LifeSciences.

Information on this page was last updated on 4/4/2022.

Glenn Coleman Insider Trading History at Integra LifeSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/4/2022Sell6,268$66.04$413,938.7241,288View SEC Filing Icon  
11/2/2021Sell4,275$74.00$316,350.00View SEC Filing Icon  
4/16/2021Sell25,658$71.50$1,834,547.0057,714View SEC Filing Icon  
4/14/2021Sell4,002$70.50$282,141.0032,056View SEC Filing Icon  
4/9/2021Sell12,500$70.00$875,000.0048,558View SEC Filing Icon  
3/29/2021Sell15,500$68.50$1,061,750.0036,058View SEC Filing Icon  
8/11/2020Sell5,000$52.27$261,350.0045,894View SEC Filing Icon  
7/24/2019Sell3,500$57.50$201,250.0035,194View SEC Filing Icon  
6/28/2019Sell3,650$55.00$200,750.0025,160View SEC Filing Icon  
8/9/2018Sell8,916$63.00$561,708.0016,795View SEC Filing Icon  
3/14/2018Sell8,769$56.10$491,940.90View SEC Filing Icon  
5/4/2017Sell13,865$45.91$636,542.1518,519View SEC Filing Icon  
5/4/2016Sell3,563$70.62$251,619.0612,263View SEC Filing Icon  
See Full Table

Glenn Coleman Buying and Selling Activity at Integra LifeSciences

This chart shows Glenn Coleman's buying and selling at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integra LifeSciences Company Overview

Integra LifeSciences logo
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $59.90
Low: $58.98
High: $60.43

50 Day Range

MA: $62.43
Low: $56.49
High: $66.77

2 Week Range

Now: $59.90
Low: $55.16
High: $76.70

Volume

196,695 shs

Average Volume

495,146 shs

Market Capitalization

$4.98 billion

P/E Ratio

32.55

Dividend Yield

N/A

Beta

1.1
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.